| Literature DB >> 35076108 |
Natalia A Osna1,2, Moses New-Aaron2,3, Raghubendra S Dagur1,2, Paul Thomes1,2, Liz Simon4, Danielle Levitt4, Patrick McTernan4, Patricia E Molina4, Hye Yeon Choi5, Keigo Machida5,6, Kenneth E Sherman7, Antonio Riva8, Sandra Phillips8, Shilpa Chokshi8, Kusum K Kharbanda1,2, Steven Weinman9, Murali Ganesan1,2.
Abstract
Progression of chronic infections to end-stage diseases and poor treatment results are frequently associated with alcohol abuse. Alcohol metabolism suppresses innate and adaptive immunity leading to increased viral load and its spread. In case of hepatotropic infections, viruses accelerate alcohol-induced hepatitis and liver fibrosis, thereby promoting end-stage outcomes, including cirrhosis and hepatocellular carcinoma (HCC). In this review, we concentrate on several unexplored aspects of these phenomena, which illustrate the combined effects of viral/bacterial infections and alcohol in disease development. We review alcohol-induced alterations implicated in immunometabolism as a central mechanism impacting metabolic homeostasis and viral pathogenesis in Simian immunodeficiency virus/human immunodeficiency virus infection. Furthermore, in hepatocytes, both HIV infection and alcohol activate oxidative stress to cause lysosomal dysfunction and leakage and apoptotic cell death, thereby increasing hepatotoxicity. In addition, we discuss the mechanisms of hepatocellular carcinoma and tumor signaling in hepatitis C virus infection. Finally, we analyze studies that review and describe the immune derangements in hepatotropic viral infections focusing on the development of novel targets and strategies to restore effective immunocompetency in alcohol-associated liver disease. In conclusion, alcohol exacerbates the pathogenesis of viral infections, contributing to a chronic course and poor outcomes, but the mechanisms behind these events are virus specific and depend on virus-alcohol interactions, which differ among the various infections.Entities:
Keywords: HBV; HCV; HIV; SIV; alcohol; liver
Mesh:
Substances:
Year: 2022 PMID: 35076108 PMCID: PMC8920772 DOI: 10.1111/acer.14777
Source DB: PubMed Journal: Alcohol Clin Exp Res ISSN: 0145-6008 Impact factor: 3.455